CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Travere Therapeutics Insider Sold Shares Worth $2,337,695, According to a Recent SEC Filing

Neutral
AI Analysis

Summary

An insider at Travere Therapeutics sold shares worth $2,337,695 according to a recent SEC filing.

Importance:1/10
Sentiment:
0.00
insider sellingSEC filing
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 7:44 AM

Read Original